Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-01-01 @ 12:50 PM
Study NCT ID:
NCT05371366
Status:
UNKNOWN
Last Update Posted:
2022-05-24
First Post:
2022-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-04-22
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-04
First Submit QC Date:
None
Study First Post Date:
2022-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-17
Last Update Post Date:
2022-05-24
Last Update Post Date Type:
ACTUAL